BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17301954)

  • 1. A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients.
    Signori E; Massi E; Matera MG; Poscente M; Gravina C; Falcone G; Rosa MA; Rinaldi M; Wuyts W; Seripa D; Dallapiccola B; Fazio VM
    Genes Chromosomes Cancer; 2007 May; 46(5):470-7. PubMed ID: 17301954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
    Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
    Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
    Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
    Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses.
    Dobson-Stone C; Cox RD; Lonie L; Southam L; Fraser M; Wise C; Bernier F; Hodgson S; Porter DE; Simpson AH; Monaco AP
    Eur J Hum Genet; 2000 Jan; 8(1):24-32. PubMed ID: 10713884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EXT1 and EXT2 mutation identified by denaturing high performance liquid chromatograph in three families with hereditary multiple exostoses].
    Zhang M; Liu SG; Li FF; Zhou WH; Jin XH; Ma X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):646-51. PubMed ID: 18067075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
    Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
    Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
    Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
    Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
    J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas.
    Jennes I; Entius MM; Van Hul E; Parra A; Sangiorgi L; Wuyts W
    J Mol Diagn; 2008 Jan; 10(1):85-92. PubMed ID: 18165274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses.
    White SJ; Vink GR; Kriek M; Wuyts W; Schouten J; Bakker B; Breuning MH; den Dunnen JT
    Hum Mutat; 2004 Jul; 24(1):86-92. PubMed ID: 15221792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.
    Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J
    Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
    Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
    Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1.
    Li H; Yamagata T; Mori M; Momoi MY
    J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
    de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
    Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
    Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
    Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
    Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
    Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
    Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation screening of EXT genes in Chinese patients with multiple osteochondromas.
    Kang Z; Peng F; Ling T
    Gene; 2012 Sep; 506(2):298-300. PubMed ID: 22820392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.